TOVX
Theriva Biologics, Inc.
Healthcare •
Biotechnology •
stocks •
XASE
• usd
$0.17
$-0.01
(-4.89%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $6.25M | EPS (ttm) | $2.06 | Current Price | $0.17 |
| Enterprise Value | $1.14M | Forward EPS | $-0.75 | Previous Close | $0.18 |
| P/E Ratio | 0.09 | ROA | -29.21% | 52W High | $1.75 |
| Forward P/E | -0.23 | ROE | -166.96% | 52W Low | $0.17 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $0.21 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $0.44 |
| P/B Ratio | 0.27 | Profit Margin | - | Volume | 1.56M |
| EV/EBITDA | -0.07 | Current Ratio | 0.90 | Avg Volume | 5.25M |
| EV/Sales | - | Quick Ratio | 0.85 | Beta | 0.57 |
| Employees | 20.00 | Debt/Equity | 40.99 | Shares Outstanding | 35.69M |
| Sector | Healthcare | Total Debt | $2.76M | Float Shares | 33.03M |
| Industry | Biotechnology | Total Cash | $7.53M | Short Float | 16.34% |
| Optionable | No | Cash/Share | $0.22 | Short Ratio | 0.57 |
| Dividend Yield | - | Book Value/Share | $0.65 | % Held by Insiders | 2.07% |
| Target Price | $7.00 | Revenue (TTM) | - | % Held by Institutions | 2.41% |